type 1 diabetes and glp-1 vs. GLP-1 + GIP: What's the Difference for your Metabolism? GLP-1 and the kidney: from

TABLE 2 The Dietary source - gut microbiota metabolites axis that promotes diseases

Potentiation of ACh release through transcutaneous vagal neuromodulation is known to enhance gut motility, reduce inflammation by suppressing TNF- , and preserve epithelial tight junction integrity through the activation of enteric glial cells (243)

Interestingly, OCT3 is associated with metformin uptake and efflux in the salivary glands, which may account for the dysgeusia associated with metformin treatment [22]

Weekly injections are the standard recommendation for the first phase of treatment

[Google Scholar] 31.Dahan K, Fennal M, Kumar NB

Finally, we observed that treatment by aminoglycoside and fluoroquinolone antibiotics, in contrast to their primary modes of action, is associated with membrane damage, lipid peroxidation, and changes in lipid composition